We read with great interest the article by Lund et al1 on selective serotonin reuptake inhibitor (SSRI) exposure in utero and pregnancy outcomes. This study, and several previous ones, demonstrated the effects of SSRI use during pregnancy on duration, birth weight, neonatal adaptation, and respiratory effects. Lund et al identified an elevated risk for low Apgar scores and neonatal intensive care unit admissions among SSRI-exposed neonates, which were not explained by the underlying psychiatric condition.
Dubnov-Raz G, Koren G, Finkelstein Y. Selective Serotonin Reuptake Inhibitor Exposure in Pregnancy and Neonatal Adverse Events. Arch Pediatr Adolesc Med. 2010;164(4):394–395. doi:10.1001/archpediatrics.2010.34
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: